Addex Therapeutics Ltd
ADXN
$6.07
$0.132.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -167.78% | -178.08% | -187.18% | -205.73% | 174.52% |
| Total Depreciation and Amortization | -91.84% | -96.45% | -83.36% | -31.94% | 1,521.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.75% | 127.48% | 123.27% | 122.13% | -584.20% |
| Change in Net Operating Assets | 98.95% | 126.96% | 2,453.93% | 279.88% | -241.95% |
| Cash from Operations | 42.88% | 65.14% | 79.78% | 86.91% | 52.41% |
| Capital Expenditure | -- | -- | 100.00% | 31.82% | 70.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.62% | -98.62% | -98.89% | -100.45% | -- |
| Cash from Investing | -98.62% | -98.62% | -98.89% | -100.48% | 102,820.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 39.77% | 92.54% | 96.17% | 97.25% | 96.25% |
| Issuance of Common Stock | 9,269.64% | 86.14% | 46.67% | -97.79% | -99.60% |
| Repurchase of Common Stock | 45.61% | 66.30% | 91.18% | 100.00% | 47.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -107.78% | 369.04% | 378.57% | 172.76% | -98.03% |
| Cash from Financing | 1,363.64% | 436.45% | 859.28% | 168.60% | -99.12% |
| Foreign Exchange rate Adjustments | 51.25% | -118.78% | 112.05% | 79.89% | 93.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 196.68% |
| Net Change in Cash | -231.62% | -104.46% | 56.88% | 72.12% | 128.57% |